期刊文献+

乌司他丁联合比阿培南治疗老年重症肺炎的临床疗效观察 被引量:28

Clinical Study on Ulinastatin Combined with Biapenem in Treatment of Elderly Patients with Severe Pneumonia
在线阅读 下载PDF
导出
摘要 观察乌司他丁联合比阿培南治疗老年重症肺炎的临床疗效,选取2013~2015年我院老年重症肺炎患者73例,随机分为对照组37例和试验组36例,对照组给予比阿培南0.3 g,加入0.9%氯化钠注射液100 mL q8h;试验组在对照组基础上加用乌司他丁注射液25万U,加入0.9%氯化钠注射液100 mL bid。两组患者均治疗2周。比较两组临床疗效,观察两组的C-反应蛋白(CRP)、降钙素原(PCT)、肿瘤坏死因子-α(TNF-α)、动脉血气指标。结果显示,对照组和试验组总有效率分别为51.3%、80.5%,两组比较差异有统计学意义(P<0.05)。治疗后,两组发热、肺部啰音及咳嗽等症状消失时间比较差异较大,有统计学意义(P<0.05)。试验组的CRP、PCT、TNF-α显著下降,动脉血气分析指标中血氧分压、二氧化碳分压、氧合指数均显著优于对照组(P<0.05)。由此认为,乌司他丁联合比阿培南在老年重症肺炎的治疗中有协同作用,联合应用可有效改善患者临床症状、降低机体炎症反应,提高疗效。 In order to observe the clinical efficacy of ulinastatin combined with biapenem in the treatment of severe pneumonia in elderly patients,73 cases of elderly severe pneumonia in our hospital from2013 to 2015 were selected and randomly divided into control group(37 cases) and experimental group.Patients in the control group were given biapenem,0.3 g in normal saline 100 mL,q8 h;those in the test group were treated with ulinastatin,250,000 U in normal saline 100 mL,bid on the basis of the control group.Patients in both groups were treated for 2 weeks.Between the two groups,the levels of CRP,PCT and TNF-α,and the clinical curative effects were compared.The results showed that the total effective rates of the control group and the experimental group were 51.3% and 80.5%,respectively,the difference between the two groups was statistically significant(P〈0.05).After treatment,the antipyretic time,the disappearance of pulmonary rales and coughing time in the experimental group were significantly shorter than those in the control group(P〈0.05).The levels of CRP,PCT and TNF-α in the experimental group were significantly decreased.The arterial blood gas analysis results of partial pressure of oxygen,partial pressure of carbon dioxide and oxygenation index were significantly superior in the control group(P〈0.05).It can be concluded that ulinastatin synergizes with biapenem in the treatment of elderly patients with severe pneumonia,the combination can effectively improve the clinical symptoms of patients,reduce the body's inflammatory response and improve efficacy.
作者 蔡楠 蒋敏 何飞 CAI Nan, JIANG Min, HE Fei(Department of Emergency Medicine, Nanjing Drum Tower Hospital, Nanjing 210008, China)
出处 《药学与临床研究》 2018年第4期308-310,共3页 Pharmaceutical and Clinical Research
关键词 注射用乌司他丁 注射用比阿培南 重症肺炎 老年人 Uliastatin for injection Biapenem for injection Severe pneumonia Elderly patients
  • 相关文献

参考文献5

二级参考文献46

  • 1李娜,孟江萍.血必净对重症肺炎患者的疗效分析[J].中国生化药物杂志,2014,34(5):61-63. 被引量:26
  • 2李胜利.胎儿肢体畸形诊断思维方法及超声诊断[J].中华医学超声杂志(电子版),2005,2(6):324-326. 被引量:34
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3072
  • 4李胜利.胎儿肢体畸形产前超声诊断及预后[J].中国实用妇科与产科杂志,2007,23(5):399-400. 被引量:42
  • 5[1]Vbvkata K, Hikida M, Yoshida, et al. In vitro activity of LJC 10,627,a new carbapenem antibiotic with high stability to dehydropeptidaseI[J]. Antimicrob Ageent Chemother, 1990,34 (6): 994-995.
  • 6柴富志治,北角和浩,石川智一,等.Biapenemの一般药理作用[J].Chemotherapy,1994,42(4):216-218.
  • 7齐藤玲,三浦敏明,多罗尾史明,等.Biapenemの体内动态に关らる研究[J].Chmotherapg,1994,42(4):277-280.
  • 8山下宪昭,河岛浩辅,野村和外,等.Biapenem の仅たずらびサルにずける体内动态[J].Chemotherapg,1994,42(4):268-271.
  • 9加藤直树,加藤はる,田中保知,等.新カルバパネム系抗菌药biapenemの嫌气性菌に对する抗菌カあすびマウス盲肠内细菌丛の影响[J].Chemothrapy,1994,42(4):55-56.
  • 10[6]Acdridge K,Morice M,Schiro D D, et al. In vitro activity of biaptnem (L-627),a new carbapenem,against anaerobes [J]. AntimicrobAgents Chemother, 1994,38 (4): 889-890.

共引文献70

同被引文献230

引证文献28

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部